Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Reusch

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 10, 2006
[Doctor protests in established areas]Michael Reusch
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 22, 2019
Wolfram Sterry, Michael Reusch
Deutsches Arzteblatt International|March 11, 2014
Manipulated evidence?Klaus Strömer, Michael Reusch
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 28, 2015
Waiting time and practice organization in dermatologyMagdalene Krensel, Matthias Augustin, Thomas Rosenbach, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 22, 2019
Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open-Label StudyTadao Akizawa, Tetsuro Otsuka, Michael Reusch, et al.
Nephron|June 25, 2020
A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on DialysisTadao Akizawa, Yusuke Yamaguchi, Tetsuro Otsuka, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|January 1, 2020
Oral roxadustat three times weekly in ESA-naïve and ESA-converted patients with anemia of chronic kidney disease on hemodialysis: Results from two phase 3 studiesTadao Akizawa, Mai Ueno, Takanori Shiga, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|November 17, 2020
Factors affecting the doses of roxadustat vs darbepoetin alfa for anemia treatment in hemodialysis patientsTadao Akizawa, Yusuke Yamaguchi, Yoshikatsu Majikawa, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 26, 2015
Methods of analyzing regional dermatological care as exemplified by the city of HamburgJobst Augustin, Stefan Erasmi, Michael Reusch, et al.
Journal of the American Society of Nephrology : JASN|March 2, 2021
Authors' ReplyTadao Akizawa, Manabu Iwasaki, Yusuke Yamaguchi, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 10, 2006
[Doctor protests in established areas]Michael Reusch
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 22, 2019
Wolfram Sterry, Michael Reusch
Deutsches Arzteblatt International|March 11, 2014
Manipulated evidence?Klaus Strömer, Michael Reusch
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 28, 2015
Waiting time and practice organization in dermatologyMagdalene Krensel, Matthias Augustin, Thomas Rosenbach, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|June 22, 2019
Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open-Label StudyTadao Akizawa, Tetsuro Otsuka, Michael Reusch, et al.
Nephron|June 25, 2020
A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on DialysisTadao Akizawa, Yusuke Yamaguchi, Tetsuro Otsuka, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|January 1, 2020
Oral roxadustat three times weekly in ESA-naïve and ESA-converted patients with anemia of chronic kidney disease on hemodialysis: Results from two phase 3 studiesTadao Akizawa, Mai Ueno, Takanori Shiga, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|November 17, 2020
Factors affecting the doses of roxadustat vs darbepoetin alfa for anemia treatment in hemodialysis patientsTadao Akizawa, Yusuke Yamaguchi, Yoshikatsu Majikawa, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 26, 2015
Methods of analyzing regional dermatological care as exemplified by the city of HamburgJobst Augustin, Stefan Erasmi, Michael Reusch, et al.
Journal of the American Society of Nephrology : JASN|March 2, 2021
Authors' ReplyTadao Akizawa, Manabu Iwasaki, Yusuke Yamaguchi, et al.
Pageof 5